Showing 641-650 of 2715 results for "".
POINT-COUNTERPOINT: Natalizumab Extended-Interval Dosing
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/point-counterpoint-natalizumab-extended-interval-dosing/30124/Optimism vs caution for using extended-interval dosing to prevent progressive multifocal leukoencephalopathy.Cluster Headache: History, Mechanisms, and Most Importantly, Treatment Options
https://practicalneurology.com/diseases-diagnoses/headache-pain/cluster-headache-history-mechanisms-and-most-importantly-treatment-options/30363/Case Report: A Woman with Tinnitus and Tongue Atrophy
https://practicalneurology.com/diseases-diagnoses/imaging-testing/case-report-a-woman-with-tinnitus-and-tongue-atrophy/30137/Glomus tumors, the great masquerader, have variable presentation and multiple treatment options.Amyotrophic Lateral Sclerosis Treatment Update
https://practicalneurology.com/diseases-diagnoses/neuromuscular/amyotrophic-lateral-sclerosis-treatment-update/30267/More treatments are available but with largely subclinical effects.The Stigma of Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-stigma-of-migraine/30276/Stigma leads to loss of status and diminished quality of life.Women & Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/women-epilepsy/31589/Biology unique to female individuals with epilepsy affects disease management significantly.MS Minute: Oral Therapies for MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-oral-therapies-for-ms/31607/The advent of oral therapies has ushered in a new phase of disease-modifying treatments.The Prevalence of Migraine and Other Neurological Conditions Among Retired National Football League Players: A Pilot Study
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-prevalence-of-migraine-and-other-neurological-conditions-among-retired-national-football-league-players-a-pilot-study/30304/Findings suggest that retired NFL players may be at increased risk for migraine, depression, anxiety, chronic pain, bedwetting, essential tremor, and Parkinson's disease.Case Report: Cyclophosphamide as Rescue Agent in Myasthenic Crisis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/case-report-cyclophosphamide-as-rescue-agent-in-myasthenic-crisis/30120/When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.Neuromuscular Notes: Diagnosing Metabolic Myopathies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-diagnosing-metabolic-myopathies/31831/Metabolic myopathies can be accurately and efficiently diagnosed by keeping key clinical features in mind.